-+ 0.00%
-+ 0.00%
-+ 0.00%

Standard BioTools Affirms FY2025 Sales Guidance of $165.000M-$175.000M vs $169.148M Est

Benzinga·08/11/2025 20:41:31
Listen to the news
Standard BioTools (NASDAQ:LAB) affirms FY2025 sales outlook from $165.000 million-$175.000 million to $165.000 million-$175.000 million vs $169.148 million estimate.